Esperion to Participate in Upcoming May Investor Conferences
April 29 2024 - 8:00AM
Esperion (NASDAQ: ESPR) today announced that the company will be
participating in the following webcasted investor events during the
month of May, which can be found on our investor relations website.
JMP Securities’ Life Sciences Conference in New York on May 13,
2024, at 2:30 p.m. ET.
Bank of America Securities’ 2024 Health Care Conference in Las
Vegas on May 15, 2024, at 3:00 p.m. PT / 6:00 p.m. ET.
H.C. Wainwright’s 2nd Annual BioConnect Investor Conference in
New York on May 20, 2024, at 10:00 a.m. ET.
Live webcasts can be accessed on the investor and media section
of the Esperion website. Access to the webcast replay will be
available approximately two hours after the completion of the call
and will be archived on the Company’s website for approximately 90
days.
Esperion TherapeuticsAt Esperion, we discover,
develop, and commercialize innovative medicines to help improve
outcomes for patients with or at risk for cardiovascular and
cardiometabolic diseases. The status quo is not meeting the health
needs of millions of people with high cholesterol – that is why our
team of passionate industry leaders is breaking through the
barriers that prevent patients from reaching their goals. Providers
are moving toward reducing LDL-cholesterol levels as low as
possible, as soon as possible; we provide the next steps to help
get patients there. Because when it comes to high cholesterol,
getting to goal is not optional. It is our life’s work. For more
information, visit esperion.com and esperionscience.com and follow
us on X at twitter.com/EsperionInc.
Esperion Contact Information:Investors:
investorrelations@esperion.com
Media: Tiffany Aldrich corporateteam@esperion.com (616)
443-8438
Esperion Therapeutics (NASDAQ:ESPR)
Historical Stock Chart
From May 2024 to Jun 2024
Esperion Therapeutics (NASDAQ:ESPR)
Historical Stock Chart
From Jun 2023 to Jun 2024